Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 12, 2012, Pages

  Caporali, Andrea ^a   Meloni, Marco ^a   Miller, Ashley M ^b   Vierlinger, Klemens ^c   Cardinali, Alessandro ^a   Spinetti, Gaia ^d   Nailor, Audrey ^a   Faglia, Ezio ^d   Losa, Sergio ^d   Gotti, Ambra ^d   Fortunato, Orazio ^d   Mitić, Tijana ^a   Hofner, Manuela ^c   Noehammer, Christa ^c   Madeddu, Paolo ^a   Emanueli, Costanza ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

diabetes mellitus; limb ischemia; p75 neurotrophin receptor; ST2; wound healing

Indexed keywords

INTERLEUKIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN RECEPTOR P75; ST2 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND CLOSURE;

ACTIVATING TRANSCRIPTION FACTOR 2; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; NERVE TISSUE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREDICTIVE VALUE OF TESTS; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; RECEPTORS, NERVE GROWTH FACTOR; STREPTOZOCIN; WOUND HEALING;

EID: 84870052859     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300497     Document Type: Article

References (47)

1. Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds. 2011;10:152-166.
2. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM. Rescue of diabetesrelated impairment of angiogenesis by intramuscular gene therapy with adenoVEGF. Am J Pathol. 1999;154:355-363. (Pubitemid 29094086)
3. Emanueli C, Caporali A, Krankel N, Cristofaro B, Van Linthout S, Madeddu P. Type2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia. Front Biosci. 2007;12:2003-2012.
4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Rutherford RB; TASC II Working Group. Intersociety consensus for the management of peripheral arterial disease. Int Angiol. 2007;26:81-157.
5. Caporali A, Pani E, Horrevoets AJ, Kraenkel N, Oikawa A, SalaNewby GB, Meloni M, Cristofaro B, Graiani G, Leroyer AS, Boulanger CM, Spinetti G, Yoon SO, Madeddu P, Emanueli C. Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetesinduced impaired neovascularization in ischemic limb muscles. Circ Res. 2008;103:e15-e26.
6. Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb postischaemic recovery in mice. Diabetologia. 2004;47:1055-1063. (Pubitemid 38918165)
7. Graiani G, Emanueli C, Desortes E, Van Linthout S, Pinna A, Figueroa CD, Manni L, Madeddu P. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice. Diabetologia. 2004;47:1047-1054. (Pubitemid 38918164)
8. Tominaga S. A putative protein of a growth specific cDNA from BALB/c3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 1989;258:301-304. (Pubitemid 20001074)
9. Iwahana H, Yanagisawa K, ItoKosaka A, Kuroiwa K, Tago K, Komatsu N, Katashima R, Itakura M, Tominaga S. Different promoter usage and multiple transcription initiation sites of the interleukin1 receptorrelated human ST2 gene in UT7 and TM12 cells. Eur J Biochem. 1999;264:397-406. (Pubitemid 29424443)
10. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA. IL33, an interleukin1like cytokine that signals via the IL1 receptorrelated protein ST2 and induces T helper type 2associated cytokines. Immunity. 2005;23:479-490. (Pubitemid 41587888)
11. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007;117:1538-1549. (Pubitemid 46871338)
12. Miller AM, Liew FY. The IL33/ST2 pathway-A new therapeutic target in cardiovascular disease. Pharmacol Ther. 2011;131:179-186.
13. Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, Lee RT. Interleukin33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail. 2009;2:684-691.
14. Choi YS, Choi HJ, Min JK, Pyun BJ, Maeng YS, Park H, Kim J, Kim YM, Kwon YG. Interleukin33 induces angiogenesis and vascular permeability through ST2/TRAF6mediated endothelial nitric oxide production. Blood. 2009;114:3117-3126.
15. Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, Baker AH, McInnes IB, Liew FY. IL33 reduces the development of atherosclerosis. J Exp Med. 2008;205:339-346.
16. Aoki S, Hayakawa M, Ozaki H, Takezako N, Obata H, Ibaraki N, Tsuru T, Tominaga S, Yanagisawa K. ST2 gene expression is proliferationdependent and its ligand, IL33, induces inflammatory reaction in endothelial cells. Mol Cell Biochem. 2010;335:75-81.
17. Bartunek J, Delrue L, Van Durme F, Muller O, Casselman F, De Wiest B, Croes R, Verstreken S, Goethals M, de Raedt H, Sarma J, Joseph L, Vanderheyden M, Weinberg EO. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J Am Coll Cardiol. 2008;52:2166-2174.
18. Mildner M, Storka A, Lichtenauer M, Mlitz V, Ghannadan M, Hoetzenecker K, Nickl S, Dome B, Tschachler E, Ankersmit HJ. Primary sources and immunological prerequisites for sST2 secretion in humans. Cardiovasc Res. 2010;87:769-777.
19. Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation. 2003;107:721-726. (Pubitemid 36222600)
20. Weir RA, Miller AM, Murphy GE, Clements S, Steedman T, Connell JM, McInnes IB, Dargie HJ, McMurray JJ. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol. 2010;55:243-250.
21. Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, Lee RT. Serum levels of the interleukin1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation. 2004;109:2186-2190. (Pubitemid 38625395)
22. PascualFigal DA, OrdoñezLlanos J, Tornel PL, Vázquez R, Puig T, Valdés M, Cinca J, de Luna AB, BayesGenis A; MUSIC Investigators. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol. 2009;54:2174-2179.
23. Barcelos LS, Duplaa C, Kränkel N, et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res. 2009;104:1095-1102.
24. Lee KF, Li E, Huber LJ, Landis SC, Sharpe AH, Chao MV, Jaenisch R. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell. 1992;69:737-749.
25. Emanueli C, Salis MB, Pinna A, Stacca T, Milia AF, Spano A, Chao J, Chao L, Sciola L, Madeddu P. Prevention of diabetesinduced microangiopathy by human tissue kallikrein gene transfer. Circulation. 2002;106:993-999. (Pubitemid 34925336)
26. Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, Bianchini G, Stillo F, Capogrossi MC, Madeddu P. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation. 2001;103:125-132. (Pubitemid 32050447)
27. Ky B, French B, McCloskey K, et al. Highsensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail. 2011;4:180-187.
28. Karasek MA. Mechanisms of angiogenesis in normal and diseased skin. Int J Dermatol. 1991;30:831-836.
29. Fadini GP, Albiero M, Menegazzo L, Boscaro E, Pagnin E, Iori E, Cosma C, Lapolla A, Pengo V, Stendardo M, Agostini C, Pelicci PG, Giorgio M, Avogaro A. The redox enzyme p66Shc contributes to diabetes and ischemiainduced delay in cutaneous wound healing. Diabetes. 2010;59:2306-2314.
30. NogalesCadenas R, CarmonaSaez P, Vazquez M, Vicente C, Yang X, Tirado F, Carazo JM, PascualMontano A. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 2009;37:W317-W322.
31. Siqueira MF, Li J, Chehab L, Desta T, Chino T, Krothpali N, Behl Y, Alikhani M, Yang J, Braasch C, Graves DT. Impaired wound healing in mouse models of diabetes is mediated by TNFalpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia. 2010;53:378-388.
32. Kumar S, Tzimas MN, Griswold DE, Young PR. Expression of ST2, an interleukin1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun. 1997;235:474-478. (Pubitemid 27326503)
33. Choi S, Friedman WJ. Inflammatory cytokines IL1β and TNFα regulate p75NTR expression in CNS neurons and astrocytes by distinct celltypespecific signalling mechanisms. ASN Neuro. 2009;1:.
34. Kumar S, Minnich MD, Young PR. ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem. 1995;270:27905-27913.
35. Caporali A, Emanueli C. Cardiovascular actions of neurotrophins. Physiol Rev. 2009;89:279-308.
36. Lau E, Ronai ZA. ATF2 at the crossroad of nuclear and cytosolic functions. J Cell Sci. 2012;125:2815-2824.
37. Küchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, De Angelis PM, Scott H, Haraldsen G. Nuclear interleukin33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol. 2008;173:1229-1242.
38. Findley CM, Mitchell RG, Duscha BD, Annex BH, Kontos CD. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;52:387-393. (Pubitemid 352001343)
39. Smadja DM, d'Audigier C, Bièche I, et al. Thrombospondin1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol. 2011;31:551-559.
40. Nakamura T, Funayama H, Kubo N, Yasu T, Kawakami M, Momomura S, Ishikawa SE. Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy. Int J Cardiol. 2009;131:186-191.
41. Becerra A, Warke RV, de Bosch N, Rothman AL, Bosch I. Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine. 2008;41:114-120.
42. Goldberg MT, Han YP, Yan C, Shaw MC, Garner WL. TNFalpha suppresses alphasmooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol. 2007;127:2645-2655. (Pubitemid 47585056)
43. Surapisitchat J, Hoefen RJ, Pi X, Yoshizumi M, Yan C, Berk BC. Fluid shear stress inhibits TNFalpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members. Proc Natl Acad Sci USA. 2001;98:6476-6481. (Pubitemid 32488262)
44. Zhao J, Chen Q, Li H, Myerburg M, Spannhake EW, Natarajan V, Zhao Y. Lysophosphatidic acid increases soluble ST2 expression in mouse lung and human bronchial epithelial cells. Cell Signal. 2012;24:77-85.
45. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P. ATF2 is preferentially activated by stressactivated protein kinases to mediate cjun induction in response to genotoxic agents. EMBO J. 1995;14:1798-1811.
46. Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, Rouleau JL, Lee RT. Expression and regulation of ST2, an interleukin1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation. 2002;106:2961-2966. (Pubitemid 35424749)
47. Matsuyama Y, Okazaki H, Tamemoto H, Kimura H, Kamata Y, Nagatani K, Nagashima T, Hayakawa M, Iwamoto M, Yoshio T, Tominaga S, Minota S. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol. 2010;37:18-25.